Picture loading failed.

Ebola Virus Disease (EVD) is a rare and deadly disease in people and nonhuman primates. The viruses that cause EVD are located mainly in sub-Saharan Africa. People can get EVD through direct contact with an infected animal (bat or nonhuman primate) or a sick or dead person infected with Ebola virus. The U.S. Food and Drug Administration (FDA) has approved the Ebola vaccine rVSV-ZEBOV (tradename "Ervebo") for the prevention of EVD. The rVSV-ZEBOV vaccine has been found to be safe and protective against only the Zaire ebolavirus species of ebolavirus.Genemedi produces core diagnostic ingredients-validated antibodies pairs Mouse anti-ebola virus (EV) monoclonal antibodies for rapid test kit of ebola virus (EV) to evaluate the related human infectious disease.The paired antibodies are both monoclonal antibody(mab).

All the antibodies and antiges of animal disease test are suitable for in functional ELISA, and other immunoassays in dignostics.The antibody can act as a capture antibody and detection antibody. Antigens are validated as positive control materials.

Order informatioin


Delivery impact due to the Coronavirus Outbreak

With the COVID-19 outbreak in the world, many flights have been cancelled. In order for the customer to receive the goods properly, we use the FedEx Customized Freight (FCF) of Fedex which demands a higher fee. If the delivery fee is more expensive in your area, we will contact you by mail.

Catalog No. Package Price(In USD) Qty (Quantity) Sum(In USD)
GMP-EV-1Ab-1mg 1mg 1043
GMP-EV-1Ab-10mg 10mg 6272
GMP-EV-1Ab-100mg 100mg 31360
GMP-EV-1Ab-xmg ≥100mg Inquiry
Shipping Cost: 760.00
Total:



Description

Antigen & Antibody Name Mouse anti-ebola virus (EV) monoclonal antibodies
Host specics Hybridoma
Source (Expression Host)Mouse IgG
Bioactivity validationAntibody Binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays in[ebola virus (EV)] level test in human infectious disease diagnositcs.
TagmFc
Products descriptionEbola Virus Disease (EVD) is a rare and deadly disease in people and nonhuman primates. The viruses that cause EVD are located mainly in sub-Saharan Africa. People can get EVD through direct contact with an infected animal (bat or nonhuman primate) or a sick or dead person infected with Ebola virus. The U.S. Food and Drug Administration (FDA) has approved the Ebola vaccine rVSV-ZEBOV (tradename "Ervebo") for the prevention of EVD. The rVSV-ZEBOV vaccine has been found to be safe and protective against only the Zaire ebolavirus species of ebolavirus.
PurityPurity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, Lateral flow immunoassay (LFIA), and other immunoassays;
FormulationSupplied as a 0.2 μM filtered solution of PBS,PH7.4.
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.